Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preerythrocytic malaria vaccine development.

Sebastian A Mikolajczak1, Ahmed S I Aly, Stefan H I Kappe

  • 1Seattle Biomedical Research Institute, Seattle, Washington 98109-5219, USA.

Current Opinion in Infectious Diseases
|September 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Biology of Malaria Parasite Liver Infection.

Cold Spring Harbor perspectives in medicine·2026
Same author

Two Plasmodium vivax hypnozoite-expressed RNA-binding proteins inhibit liver stage replication.

Nature communications·2026
Same author

A drug repurposing approach reveals targetable epigenetic pathways in <i>Plasmodium vivax</i> hypnozoites.

eLife·2025
Same author

Advantages of outcrossing in <i>Plasmodium falciparum</i>: insights from genetic crosses using fluorescent labelled parasites.

bioRxiv : the preprint server for biology·2025
Same author

Elimination of intra-hepatocytic malaria parasites is driven by non-canonical autophagy but not nitric oxide production.

iScience·2025
Same author

Generation of a Transgenic <i>Plasmodium cynomolgi</i> Parasite Expressing <i>Plasmodium vivax</i> Circumsporozoite Protein for Testing <i>P. vivax</i> CSP-Based Malaria Vaccines in Non-Human Primates.

Vaccines·2025

Developing effective preerythrocytic malaria vaccines is crucial for global health. Live attenuated sporozoite vaccines and novel antigen discovery show promise in preventing malaria infection.

Area of Science:

  • Malariology
  • Vaccinology
  • Infectious Diseases

Background:

  • Malaria remains a significant global health burden, necessitating novel vaccine strategies.
  • The preerythrocytic stage of the malaria parasite lifecycle is a key target for vaccine development.

Purpose of the Study:

  • To review current preerythrocytic malaria vaccine approaches.
  • To assess their potential in reducing the global malaria burden.

Main Methods:

  • Review of existing literature on preerythrocytic malaria vaccine candidates.
  • Analysis of data from preclinical and clinical studies.
  • Evaluation of challenges and advancements in vaccine development and production.

Main Results:

Related Experiment Videos

  • Radiation-attenuated parasite vaccines demonstrate potential for sterile protection but face production and safety challenges.
  • Subunit vaccines targeting circumsporozoite protein (CSP) show limited efficacy in endemic areas.
  • Rodent models suggest CSP immunity is not essential for sterile protection.

    • Conclusions:

    • Future efforts should prioritize developing safe, live attenuated sporozoite vaccines for accelerated testing in malaria-endemic regions.
    • Identifying novel antigens that elicit sterilizing immunity, similar to whole parasite vaccines, is critical.
    • The sporozoite challenge model offers a valuable platform for rapid evaluation of vaccine candidates.